154 related articles for article (PubMed ID: 2785665)
1. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in Macaca fascicularis.
Levi AC; DeMattei M; Ravazzani R; Corvetti G; Golden GT; Fariello RG
Neurosci Lett; 1989 Jan; 96(3):271-6. PubMed ID: 2785665
[TBL] [Abstract][Full Text] [Related]
2. Neuromelanic pigment in substantia nigra neurons of rats and dogs.
DeMattei M; Levi AC; Fariello RG
Neurosci Lett; 1986 Dec; 72(1):37-42. PubMed ID: 3492690
[TBL] [Abstract][Full Text] [Related]
3. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
Nature; 1987 May 28-Jun 3; 327(6120):324-6. PubMed ID: 2884568
[TBL] [Abstract][Full Text] [Related]
4. The action of MPTP on Macaca fascicularis nigral neurons.
Levi AC; De Mattei M; Ravazzani R; Fariello GR; Corvetti G
Boll Soc Ital Biol Sper; 1987 Apr; 63(4):365-8. PubMed ID: 3502324
[No Abstract] [Full Text] [Related]
5. Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey.
Tanaka J; Nakamura H; Honda S; Takada K; Kato S
Acta Neuropathol; 1988; 75(4):370-6. PubMed ID: 3259063
[TBL] [Abstract][Full Text] [Related]
6. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
Burns RS; Markey SP; Phillips JM; Chiueh CC
Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
[TBL] [Abstract][Full Text] [Related]
7. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria covered with a net of parallel and latticed filaments in nigral neurons of monkeys with experimental parkinsonism.
Nakamura H; Kato S; Tanaka J
Acta Neuropathol; 1989; 77(5):489-93. PubMed ID: 2785741
[TBL] [Abstract][Full Text] [Related]
9. Neuromelanin: a role in MPTP-induced neurotoxicity.
D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
Life Sci; 1987 Feb; 40(8):705-12. PubMed ID: 2880274
[TBL] [Abstract][Full Text] [Related]
10. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
German DC; Dubach M; Askari S; Speciale SG; Bowden DM
Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
[TBL] [Abstract][Full Text] [Related]
11. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.
Imai H; Nakamura T; Endo K; Narabayashi H
Brain Res; 1988 Dec; 474(2):327-32. PubMed ID: 3264746
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin.
D'Amato RJ; Benham DF; Snyder SH
J Neurochem; 1987 Feb; 48(2):653-8. PubMed ID: 3491879
[TBL] [Abstract][Full Text] [Related]
13. Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.
Mochizuki H; Imai H; Endo K; Yokomizo K; Murata Y; Hattori N; Mizuno Y
Neurosci Lett; 1994 Feb; 168(1-2):251-3. PubMed ID: 8028787
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.
D'Amato RJ; Lipman ZP; Snyder SH
Science; 1986 Feb; 231(4741):987-9. PubMed ID: 3080808
[TBL] [Abstract][Full Text] [Related]
15. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
Biesemeier A; Eibl O; Eswara S; Audinot JN; Wirtz T; Pezzoli G; Zucca FA; Zecca L; Schraermeyer U
J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
Waters CM; Hunt SP; Jenner P; Marsden CD
Neuroscience; 1987 Dec; 23(3):1025-39. PubMed ID: 2893993
[TBL] [Abstract][Full Text] [Related]
17. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
Schneider JS; Yuwiler A; Markham CH
Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180
[TBL] [Abstract][Full Text] [Related]
18. The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset.
Gibb WR; Lees AJ; Jenner P; Marsden CD
Neurosci Lett; 1986 Mar; 65(1):79-83. PubMed ID: 3486388
[TBL] [Abstract][Full Text] [Related]
19. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.
Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
Neurosci Lett; 1985 Oct; 61(1-2):195-200. PubMed ID: 3878482
[TBL] [Abstract][Full Text] [Related]
20. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey.
Langston JW; Forno LS; Rebert CS; Irwin I
Brain Res; 1984 Feb; 292(2):390-4. PubMed ID: 6607092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
